Catalyst Wire Dossier Catalyst Wire Dossier

ABT-614

· Abbott
Drug timelines are a Plus or Pro feature.

3 regulatory and trial events tracked for ABT-614, covering 2010-11-02 to 2012-08-22. Get the full timeline:

Most recent: Clinical Trial Update: A Study to Evaluate the Safety and Tolerability of ABT-614 and Its Effect on Kidney Function in Subjects With Type 2 Diabetes and Chronic Kidney Disease With Protein in Their Urine. [Phase 1]

See pricing